Metastatic Colorectal Cancer (CRC)

Explore clinical trials studying Metastatic Colorectal Cancer (CRC). Study availability and eligibility vary by location and protocol.

37 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer (CRC) trial results

Not yet recruiting

QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC

NCT07009145

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Not yet recruiting

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

NCT06959693

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Medical Oncology,Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Evaluation of the Effect of Adapted Physical Activity on the Modification of Lipid Metabolism During Chemotherapy for Metastatic COLorectal Cancer

NCT06944548

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: Centre Georges-François Leclerc Dijon, France

CHU Dijon (clinical investigation centre) Dijon, France

View Trial Details

Not yet recruiting

The Study on the Efficacy and Safety of Lactobacillus Johnsonii in Combination with CapeOX and Pembrolizumab for the Treatment of MSS/pMMR Metastatic Colorectal Cancer.

NCT06823323

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer

NCT06849362

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Xiangya hospital, CSU Changsha, Hunan, China

View Trial Details

Active, not recruiting

Impact of Fusobacterium Nucleatum on Response to Anti-EGFR Therapy in Metastatic Colorectal Cancer

NCT07619859

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Barretos Cancer Hospital Barretos, São Paulo, Brazil

View Trial Details

Active, not recruiting

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

NCT06784947

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +21 more
Locations: Universtiy of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Metastatic Colorectal Cancer (CRC)

Metastatic Colorectal Cancer (CRC) trial results

QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Evaluation of the Effect of Adapted Physical Activity on the Modification of Lipid Metabolism During Chemotherapy for Metastatic COLorectal Cancer

The Study on the Efficacy and Safety of Lactobacillus Johnsonii in Combination with CapeOX and Pembrolizumab for the Treatment of MSS/pMMR Metastatic Colorectal Cancer.

Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer

Impact of Fusobacterium Nucleatum on Response to Anti-EGFR Therapy in Metastatic Colorectal Cancer

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

Related conditions